# Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasma

> **NIH NIH UL1** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2020 · $562,991

## Abstract

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is a highly functional
and integrated clinical and translational (C&T) research infrastructure that has raised the quality
and scientific rigor of the research conducted at Vanderbilt and longstanding partner Meharry,
the nation's oldest historically black academic health science institution. VICTR will contribute to
the mission of the CTSA program while leveraging unique resources and expertise within
VICTR's Hub with these aims: 1) Leverage VICTR's strong collaborative energy to enhance
team science methodologies that propel transdisciplinary research approaches, and integrate
proven community engagement principles to stakeholders for all stages of research; 2) Develop,
implement and disseminate informatics and data organization methods to promulgate research
efficiency, quality, and preparedness and integrate data collection in the conduct of pragmatic
trials; 3) Ensure the translational science workforce is diverse and has the skills, knowledge,
and resources necessary to advance translation of discoveries; 4) Measurably improve the
efficiency, quality, and representativeness of C&T studies by enhancing and systematically
integrating services and programs that support highest quality research initiation and conduct;
5) Measurably improve the efficiency and quality of multi-site clinical trials, in collaboration with
the TICs and RICs, by leveraging centralized regulatory and legal agreements, providing rapid
feasibility and recruitment methods and practices, and creating and disseminating novel clinical
trial designs and methodologies; and 6) Utilize unique strengths leveraging novel resources
BioVU and PheWAS to guide drug development and repurposing.

## Key facts

- **NIH application ID:** 10254565
- **Project number:** 3UL1TR002243-04S4
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** Gordon Raphael Bernard
- **Activity code:** UL1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $562,991
- **Award type:** 3
- **Project period:** 2020-09-18 → 2022-02-28

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10254565

## Citation

> US National Institutes of Health, RePORTER application 10254565, Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasma (3UL1TR002243-04S4). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10254565. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*